当前位置:首页 - 行情中心 - 科兴制药(688136) - 财务分析 - 现金流量表

科兴制药

(688136)

  

流通市值:46.23亿  总市值:46.23亿
流通股本:2.02亿   总股本:2.02亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金705,938,520.24343,983,364.971,359,794,670.67901,682,476.95
  收到的税费返还3,731,292.12-3,153,719.031,350,046.21
  收到其他与经营活动有关的现金8,809,498.362,701,449.0335,688,289.2626,422,211.75
  经营活动现金流入小计718,479,310.72346,684,8141,398,636,678.96929,454,734.91
  购买商品、接受劳务支付的现金224,018,044.09128,156,336.13402,160,745.99276,678,071.15
  支付给职工以及为职工支付的现金140,310,822.1660,064,660.7238,996,543.26177,754,043.27
  支付的各项税费42,687,268.2819,751,892.8360,910,754.4543,084,190.75
  支付其他与经营活动有关的现金286,217,531.01131,794,494.83610,539,749.47439,195,957.93
  经营活动现金流出小计693,233,665.54339,767,384.491,312,607,793.17936,712,263.1
  经营活动产生的现金流量净额25,245,645.186,917,429.5186,028,885.79-7,257,528.19
二、投资活动产生的现金流量:
  收回投资收到的现金321,000,000285,000,0001,762,898,600.241,334,743,697.83
  取得投资收益收到的现金2,767,879.392,714,761.5816,332,713.2412,878,974.88
  处置固定资产、无形资产和其他长期资产收回的现金净额145,900125,0001,165,9701,158,970
  处置子公司及其他营业单位收到的现金净额--13,499,888.7413,499,888.74
  收到的其他与投资活动有关的现金1,764,000128,000577,000557,000
  投资活动现金流入小计325,677,779.39287,967,761.581,794,474,172.221,362,838,531.45
  购建固定资产、无形资产和其他长期资产支付的现金36,703,696.3913,194,123.2883,626,674.8250,637,515.76
  投资支付的现金405,000,000299,000,0001,770,850,0001,465,850,000
  取得子公司及其他营业单位支付的现金--1,072,4401,072,440
  支付其他与投资活动有关的现金14,928,170.5614,128,170.562,687,0001,142,000
  投资活动现金流出小计456,631,866.95326,322,293.841,858,236,114.821,518,701,955.76
  投资活动产生的现金流量净额-130,954,087.56-38,354,532.26-63,761,942.6-155,863,424.31
三、筹资活动产生的现金流量:
  吸收投资收到的现金8,492,842.5-19,250,80019,250,800
  取得借款收到的现金379,041,215.2143,900,000916,430,061.72709,641,541.72
  收到其他与筹资活动有关的现金--118,847.04118,847.04
  筹资活动现金流入小计387,534,057.7143,900,000935,799,708.76729,011,188.76
  偿还债务支付的现金349,352,275.99142,871,849.54732,420,199.44526,862,283.43
  分配股利、利润或偿付利息支付的现金70,642,877.9310,325,036.5957,383,991.6546,721,329.21
  支付其他与筹资活动有关的现金12,556,135.379,863,724.272,681,420.7655,042,650.96
  筹资活动现金流出小计432,551,289.29163,060,610.33862,485,611.85628,626,263.6
  筹资活动产生的现金流量净额-45,017,231.59-19,160,610.3373,314,096.91100,384,925.16
四、汇率变动对现金及现金等价物的影响-4,631,923.51-2,536,495.53-210,761.57786,051.79
五、现金及现金等价物净增加额-155,357,597.48-53,134,208.6195,370,278.53-61,949,975.55
  加:期初现金及现金等价物余额648,322,221.12648,322,221.12552,951,942.59552,951,942.59
  期末现金及现金等价物余额492,964,623.64595,188,012.51648,322,221.12491,001,967.04
补充资料:
  净利润132,477,247.74-152,744,259.08-
  资产减值准备1,517,706.62-2,342,216.31-
  固定资产和投资性房地产折旧35,485,611.03-70,268,337.55-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧35,485,611.03-70,268,337.55-
  无形资产摊销14,664,040.71-27,702,947.65-
  长期待摊费用摊销3,120,224.37-6,061,405.93-
  处置固定资产、无形资产和其他长期资产的损失-22,729.26--954,825.69-
  固定资产报废损失206,854.46-610,458.29-
  公允价值变动损失-245,632,832.01--79,288,219.78-
  财务费用25,754,828.5-42,847,352.41-
  投资损失-2,795,710.37--30,771,240.12-
  递延所得税10,444,207.01-9,264,233.76-
  其中:递延所得税资产减少-27,471,967.7--2,257,007.17-
    递延所得税负债增加37,916,174.71-11,521,240.93-
  存货的减少1,508,759.63-252,070.47-
  经营性应收项目的减少52,219,801.11--224,910,029.88-
  经营性应付项目的增加-10,016,031.53-92,912,249.38-
  其他770,660.29-5,183,766.88-
  现金的期末余额492,964,623.64-648,322,221.12-
  减:现金的期初余额648,322,221.12-552,951,942.59-
  现金及现金等价物的净增加额-155,357,597.48-95,370,278.53-
公告日期2026-08-222026-04-292026-04-222025-10-30
审计意见(境内)标准无保留意见
TOP↑